Estrogens and the risk of complex regional pain syndrome (CRPS)

Marissa Mos, Frank Huygen, Bruno Stricker, Jeanne Dieleman, MCJM Sturkenboom

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)


Objective Since complex regional pain syndrome (CRPS) shows a clear female predominance, we investigated the association between the cumulative as well as current exposure to estrogens, and CRPS. Methods A population-based case-control study was conducted in the Integrated Primary Care Information (IPCI) project in the Netherlands. Cases were identified from electronic records (1996-2005) and included if they were confirmed during a visit (using International Association for the Study of Pain Criteria), or had been diagnosed by a specialist. Controls were matched to cases on gender, age, calendar time, and injury. Measures of cumulative endogenous estrogen exposure were obtained by questionnaire and included age of menarche and menopause, menstrual life, and cumulative months of pregnancy and breast-feeding. Current estrogen exposure at CRPS onset was retrieved from the electronic medical records and determined by current pregnancy or by the use of oral contraceptive (OC) drugs or hormonal replacement therapy (HRT). Results Hundred and forty-three female cases (1493 controls) were included in analyses on drug use and pregnancies, while cumulative endogenous estrogen exposure was studied in 53 cases (58 controls) for whom questionnaire data were available. There was no association between CRPS and either cumulative endogenous estrogen exposure, OC, or HRT use. CRPS onset was increased during the first 6 months after pregnancy (OR: 5.6, 95%CI: 1.0-32.4), although based on small numbers. Discussion We did not find an association between CRPS onset and cumulative endogenous estrogen exposure or current OC or HRT use, but more powered studies are needed to exclude potential minor associations. Copyright (C) 2008 John Wiley & Sons, Ltd.
Original languageUndefined/Unknown
Pages (from-to)44-52
Number of pages9
JournalPharmacoepidemiology and Drug Safety
Issue number1
Publication statusPublished - 2009

Research programs

  • EMC NIHES-01-64-03
  • EMC NIHES-03-77-02

Cite this